Activities of prolyl endopeptidase and dipeptidyl peptidase IV in brain structures of rats with dopamine deficiency-dependent MPTP-induced depressive syndrome

Bulletin of Experimental Biology and Medicine

Volumn 142, Issue 5, 2006, Pages 554-556

  Krupina, N A ^a   Zolotov, N N ^a   Bogdanova, N G ^a   Orlova, I N ^a   Khlebnikova, N N ^a   Kryzhanovskii, G N ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

Brain; Dipeptidyl peptidase IV; MPTP induced depressive syndrome; Proline endopeptidase; Rats

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIPEPTIDYL PEPTIDASE IV; DOPAMINE; PROLYL ENDOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DISEASE COURSE; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; FRONTAL CORTEX; MALE; NONHUMAN; PATHOGENESIS; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIGENS, CD26; BRAIN; CEREBRAL CORTEX; DEPRESSIVE DISORDER; DOPAMINE; HYPOTHALAMUS; MALE; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES;

RATTUS;

EID: 33947710069     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0416-5     Document Type: Article

References (15)

1. N. N. Zolotov, V. B. Narkevich, A. V. Prikhozhan, et al., Dokl. Akad. Nauk, 322, No. 4, 624-626 (1992).
2. N. A. Krupina and G. N. Kryzhanovskii, Zh. Nevrol. Psikhiatr., No. 4, 42-47 (2003).
3. N. A. Krupina, I. N. Orlova, and G. N. Kryzhanovskii, Zh. Vyssh. Nervn. Deyat., 49, No. 5, 865-876 (1999).
4. G. N. Kryzhanovskii, N. A. Krupina, and V. G. Kucheryanu, Ibid., 45, No. 2, 377-387 (1995).
5. V. B. Narkevich, G. A. Nazarova, N. N. Zolotov, et al., Dokl. Akad. Nauk, 339, No. 5, 691-693 (1994).
6. S. Al-Damluji, Curr. Drugs Targets. CNS Neurol. Disord., 3, No. 3, 201-216 (2004).
7. P. L. Delgado, J. Clin. Psychiatry, 61, Suppl. 6, 7-11 (2000).
8. J. J. Indanpaan-Heikkila, P. Rauhala, R. K. Tuominen, et al., Pharmacol. Toxicol., 78, No. 3, 129-135 (1996).
9. Y. Iton, A. Yamazaki, Y. Ukai, et al., Ibid., 78, No. 6, 421-428 (1996).
10. M. Maes, F. Goossens, S. Scharpe, et al., Biol. Psychiatry, 35, No. 8, 545-552 (1994).
11. M. Maes, I. De Meester, G. Vanhoof, et al., Ibid., 30, No. 6, 577-586 (1991).
12. P. T. Mannisto, P. Tuomainen, O. Kutepova, et al., Pharmacol. Biochem. Behav., 49, No. 1, 33-40 (1994).
13. K. I. Natban, D. L. Musselman, A. F. Schatzberg, et al., Textbook of Psychopharmacology, Washington, London (1995), pp. 439-477.
14. D. F. Swaab, A. V. Bao, and P. J. Lucassen, Ageing Res. Rev., 4, No. 2, 141-194 (2005).
15. D. De Wied and H. O. Sigling, Neurotox. Res., 4, Nos. 5-6, 453-468 (2002).